ID   NR2C2_RAT               Reviewed;         596 AA.
AC   P55094;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   07-APR-2021, entry version 146.
DE   RecName: Full=Nuclear receptor subfamily 2 group C member 2;
DE   AltName: Full=Orphan nuclear receptor TR4;
DE   AltName: Full=Testicular receptor 4;
GN   Name=Nr2c2; Synonyms=Tr4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Hypothalamus, and Prostate;
RX   PubMed=8016112; DOI=10.1073/pnas.91.13.6040;
RA   Chang C., da Silva S.L., Ideta R., Lee Y., Yeh S., Burbach J.P.;
RT   "Human and rat TR4 orphan receptors specify a subclass of the steroid
RT   receptor superfamily.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:6040-6044(1994).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=9556573; DOI=10.1074/jbc.273.18.10948;
RA   Yan Z.H., Karam W.G., Staudinger J.L., Medvedev A., Ghanayem B.I.,
RA   Jetten A.M.;
RT   "Regulation of peroxisome proliferator-activated receptor alpha-induced
RT   transactivation by the nuclear orphan receptor TAK1/TR4.";
RL   J. Biol. Chem. 273:10948-10957(1998).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Orphan nuclear receptor that can act as a repressor or
CC       activator of transcription. An important repressor of nuclear receptor
CC       signaling pathways such as retinoic acid receptor, retinoid X, vitamin
CC       D3 receptor, thyroid hormone receptor and estrogen receptor pathways.
CC       May regulate gene expression during the late phase of spermatogenesis.
CC       Activates transcriptional activity of LHCG and is antagonist of PPARA-
CC       mediated transactivation. Together with NR2C1, forms the core of the
CC       DRED (direct repeat erythroid-definitive) complex that represses
CC       embryonic and fetal globin transcription including that of GATA1. Binds
CC       to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half
CC       site direct repeat consensus sequences. Plays a fundamental role in
CC       early embryonic development and embryonic stem cells. Required for
CC       normal spermatogenesis and cerebellum development. Appears to be
CC       important for neurodevelopmentally regulated behavior (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer; can bind DNA as homodimer. Heterodimer; binds DNA
CC       as a heterodimer with NR2C1 required for chromatin remodeling and for
CC       binding to promoter regions such as globin DR1 repeats. Interacts with
CC       NR2C2AP; the interaction represses selective NR2C2-mediated
CC       transcriptional activity. Interacts with PCAF; the interaction
CC       preferentially occurs on the non-phosphorylated form and induces NR2C2-
CC       mediated transactivation activity and does not require the ligand-
CC       binding domain. Interacts (MAPK-mediated phosphorylated form) with
CC       NRIP1; the interaction promotes repression of NR2C2-mediated activity.
CC       Interacts with NLRP10. Interacts (via ligand-binding region) with
CC       transcriptional corepressor JAZF1; the interaction promotes NR2C2-
CC       mediated transcriptional repression. {ECO:0000250|UniProtKB:P49116,
CC       ECO:0000250|UniProtKB:P49117}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00407}.
CC   -!- TISSUE SPECIFICITY: Expressed in hepatocytes. Also expressed in granule
CC       cells of the hippocampus and the cerebellum.
CC       {ECO:0000269|PubMed:8016112, ECO:0000269|PubMed:9556573}.
CC   -!- PTM: Phosphorylation on Ser-19 and Ser-68 is an important regulator of
CC       NR2C2-mediated transcriptional activity. Phosphorylation on these
CC       residues recruits the corepressor, NRIP1, leading to transcripional
CC       repression, whereas the non-phosphorylated form preferentially recruits
CC       the coactivator, PCAF (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR2
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L27513; AAA21475.1; -; mRNA.
DR   PIR; I80177; I80177.
DR   RefSeq; NP_059019.1; NM_017323.1.
DR   STRING; 10116.ENSRNOP00000014354; -.
DR   iPTMnet; P55094; -.
DR   PhosphoSitePlus; P55094; -.
DR   PaxDb; P55094; -.
DR   GeneID; 50659; -.
DR   KEGG; rno:50659; -.
DR   UCSC; RGD:3201; rat.
DR   CTD; 7182; -.
DR   RGD; 3201; Nr2c2.
DR   eggNOG; KOG3575; Eukaryota.
DR   InParanoid; P55094; -.
DR   OrthoDB; 278171at2759; -.
DR   PhylomeDB; P55094; -.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   PRO; PR:P55094; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0004879; F:nuclear receptor activity; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0048856; P:anatomical structure development; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0021549; P:cerebellum development; ISO:RGD.
DR   GO; GO:0051321; P:meiotic cell cycle; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0038066; P:p38MAPK cascade; ISO:RGD.
DR   GO; GO:0048520; P:positive regulation of behavior; ISO:RGD.
DR   GO; GO:0040019; P:positive regulation of embryonic development; ISO:RGD.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Differentiation; DNA-binding; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Receptor; Reference proteome;
KW   Repressor; Spermatogenesis; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..596
FT                   /note="Nuclear receptor subfamily 2 group C member 2"
FT                   /id="PRO_0000053590"
FT   DOMAIN          341..583
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        114..189
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         117..137
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         153..177
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   MOD_RES         19
FT                   /note="Phosphoserine; by MAPK"
FT                   /evidence="ECO:0000250|UniProtKB:P49116"
FT   MOD_RES         46
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49116"
FT   MOD_RES         55
FT                   /note="Phosphoserine; by MAPK"
FT                   /evidence="ECO:0000250|UniProtKB:P49117"
FT   MOD_RES         68
FT                   /note="Phosphoserine; by MAPK"
FT                   /evidence="ECO:0000250|UniProtKB:P49116"
FT   MOD_RES         98
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49116"
FT   MOD_RES         219
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         231
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P49117"
FT   CROSSLNK        192
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P49116"
SQ   SEQUENCE   596 AA;  65344 MW;  A5A7E7C1FFBB6B70 CRC64;
     MTSPSPRIQI ISTDSAVRSP QRIQIVTDQQ TGQKLQIVTA VDASGSSKQQ FILTSPDGAG
     TGKVILASPE TSSAKQLIFT TSDNLVPGRI QIVTDSASVE RLLGKADVQR PQVVEYCVVC
     GDKASGRHYG AVSCEGCKGF FKRSVRKNLT YSCRSSQDCI INKHHRNRCQ FCRLKKCLEM
     GMKMESVQSE RKPFDVQREK PSNCAASTEK IYIRKDLRSP LIATPTFVAD KDGSRQTGLL
     DPGMLVNIQQ PLIREDGTVL LATDSKAETS QGALGTLANV VTSLANLSES LNNGDASEMQ
     PEDQSASEIT RAFDTLAKAL NTTDSASPPS LADGIDASGG GSIHVISRDQ STPIIEVEGP
     LLSDTHVTFK LTMPSPMPEY LNVHYICESA SRLLFLSMHW ARSIPAFQAL GQDCNTSLVR
     ACWNELFTLG LAQCAQVMSL STILAAIVNH LQNSIQEDKL SGDRIKQVME HIWKLQEFCN
     SMAKLDIDGH EYAYLKAIVL FSPDHPGLTG TSQIEKFQEK AQMELQDYVQ KTYSEDTYRL
     ARILVRLPAL RLMSSNITEE LFFTGLIGNV SIDSIIPYIL KMETAEYNGQ ITGASL
//
